Press releases
- LivaNova to Present at the Goldman Sachs Healthcare Conference
- LivaNova Reports First-Quarter 2024 Results
- LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
- LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
- LivaNova to Announce First-Quarter 2024 Results
- LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
More ▼
Key statistics
On Monday, LivaNova PLC (L2IV34:SAO) closed at 39.40, 0.51% above its 52-week low of 39.20, set on May 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.46 |
---|---|
High | 39.46 |
Low | 39.40 |
Bid | 39.45 |
Offer | 39.64 |
Previous close | 39.40 |
Average volume | 12.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 03 2024 20:49 BST.
More ▼